https://www.avient.com/sites/default/files/2022-12/Mevopur Colors for Ophthalmic Closures Application Bulletin_A4.pdf
This portfolio is based on a PE carrier, but can be
provided in a PP carrier on request.
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified
manufacturing sites, providing global
consistency and increased security of supply
• Documented change control beyond CAS
number, reducing risk of change
• Non-phthalate and formulated without animal-
derived substances
• Standard concentrates in a PE carrier and
on request in PP
• Pre-colored formulations can be supplied in
specific resins selected for the application
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1 and USP biological
evaluation
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
• Registered Drug Master File (Type III)
• Food contact established with FDA/EU*
APPLICATION BULLETIN
DRUG TYPE COLOR
DESCRIPTION
PANTONE
REFERENCE
AVIENT PRODUCT
CODE PE BASED
Adrenergic agonist
combinations Light Green 373 C PE6M176349
Adrenergic agonists Purple 2583 C PE4M176057
Anti-infectives Tan 467 C PE8M176130
Anti-inflammatory,
nonsteroidal Grey Cool Grey 4 C PE7M176184
steroids Pink 197 C PE3M176237
Anti-inflammatory,
immunomodulators Olive Green 5763 C On request
Beta-blockers Yellow Yellow C PE1M176160
Beta-blocker combinations Dark Blue 281 C PE5M176272
Carbonic anhydrase inhibitors Orange 1585 C PE2M176089
Cytotoxic Black 6 C PL9M176008
Miotics Dark Green 348 C PE6M176267
Mydriatics and cycloplegics Red 1797 C PE3M176236
Prostaglandin analogues Turquoise 326 C PE5M176273
Healthcare use limitations apply—see below.
For containers/bottles, Avient also offers Remafin™ EP White Colorants,
available in low density and high density PE and PP resins.
https://www.avient.com/sites/default/files/2020-10/luxury-closures-gravi-tech-design-guide-2.0-application-specific.pdf
CHAPTER 1 | APPLICATION SUMMARY
Design Guide 5
GT5200-0013
GT6000-0004
GT7300-0006
GT5200-5003
GT6000-5002
GT7300-5007
Specific
Gravity* 2.0 3.0 2.0 2.5 2.6 2.2
Color
Options* Various Various Black to Grey Black Various Various
Electroplating No Possibly Yes Possibly Possibly Yes
Base
Resin PP PA6 ABS PP PA6 ABS
FDA
Compliant* Yes Yes Yes Yes No Yes
Region
Produced
North
America
North
America
North
America Europe Europe Europe
Full
Name
X GT5200-0013
PT White
X GT6000-0004
PT White
X GT7300-0006
PT Black
GT7300-5003
Black FD
GT6000-5002
EI White 1
GT7300-5007
X2 White FD
*Please contact Avient for additional information
6 Gravi-Tech
CHAPTER 2 | PROCESS SETTINGS
Density Modified Formulations
Gravi-Tech™ polymer-metal composites are high-density materials developed as thermoplastic-
based alternatives to metals.
The shot size
of the machine needs to be large enough to fill
the part completely and allow for a cushion.
Optimizing Injection Velocity
The objective of this step is to find where the
injection velocity will fill out the part completely,
and not pressure limit the machine.
https://www.avient.com/sites/default/files/2024-05/Complet LFT Step Linkage case study snapshot_aftermarket.pdf
AFTERMARKET PARTS
MANUFACTURER
S T E P L I N K A G E
• Maintain performance qualities of incumbent aluminum
part (UV, weatherability, and structural integrity) while also
reducing cost
• Eliminate rust and corrosion concerns
• Increase throughput and streamline manufacturing
• Outperformed coated die cast aluminum and
reduced part costs by 40%
• Delivered moisture-resistant PA66 formulation
to eliminate powder coating and implement a
one-step, injection molding process
• Expanded design options through advanced
design and polymer expertise
• Utilized advanced simulation software to build
confidence in the final part performance
Complēt™ Long Fiber Reinforced Structural
Thermoplastics
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/products/long-fiber-technology/complet-moisture-resistant-nylons
https://www.avient.com/sites/default/files/2025-02/case study snapshot -Knee RAIL brace LFT.pdf
PowerPoint Presentation
PROSTHETICS AND
ORTHOTICS BRAND
K N E E R A I L & B R A C E
• Replace metal to reduce weight
• Update design to achieve slimmer design
• Offer excellent strength and modulus properties
• Improve durability with better fatigue resistance than
incumbent aluminum
• Increased design freedom and
lightweighting for metal replacement
applications while meeting structural needs
• Delivered excellent fatigue endurance and
moisture resistance for enhanced durability
• Achieved cost reduction per part by
switching to an injection molding process
Complēt Long Carbon Fiber Reinforced
Structural Thermoplastics
WHY AVIENT?
https://www.avient.com/products/long-fiber-technology/complet-long-carbon-fiber
Slide 1: prosthetics and orthotics BRAND
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Critical%2520Imperatives.pdf
Page 102
Critical Imperatives – Medium to Long Term
• Continue cultural and paradigm shift from
commodity compounder to collaborative formulator
as One PolyOne
• Accelerate innovation and leverage megatrends to
improve our mix of business with higher-margin improve our mix of business with higher-margin
specialty products
• Increase specialty contribution and advance
globalization via acquisitions
• Drive relentless execution and creative innovation as
key competitive differentiators
Page 103
2011
Proforma ColorMatrix
2015 Target
“Where we are” “Where we expect to be”
1) Operating Income %
Specialty 8.9%
PP&S 7.2%
12 – 16%
9 – 12%
Elevating our Expectations and Yours
PP&S 7.2%
Distribution 5.6%
2) Specialty Platform
% of Operating Income
50%
3) ROIC* (after-tax) 10%
4) Adjusted Annual
EPS Growth
3 yr CAGR = 71%
9 – 12%
6 – 7.5%
65 – 75%
15%
Double Digit Expansion
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
Page 104
https://www.avient.com/sites/default/files/2023-08/Hydrocerol Chemical Foaming Agents - PP Door Panel - Application Snapshot 2.pdf
https://www.avient.com/sites/default/files/2021-10/versaflex-top-cover-of-air-cushion-powder-case-study-one-pager.pdf
Cosmetic brands
COSMETIC BRANDS
C O V E R O F A I R C U S H I O N
P O W D E R C O M P A C T
• Low coefficient of friction (COF) to balance the opening
pressure and sealing performance
• General FDA compliance
• Good chemical resistance and barrier protection to water
and oxygen
• Overmold to PP with good compression set
• Delivered chemically resistant material with
excellent sealing properties and good
resilience to achieve requested
performance
• Provided onsite technical support to
improved injection speed and achieve good
bonding performance
• Offered a material solution that could be
leveraged across the customer’s global
cosmetic brands
Custom Versaflex™ TPE
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2024-03/Versalloy TPE Waterproof Seal on Vehicle Accessory.pdf
AUTOMOTIVE OEM
W A T E R P R O O F S E A L O N
A C C E S S O R Y P A R T
• FDA food contact compliance
• Color match to OEM-specified gray
• 70 Shore A durometer for overmolding to PP
• Scratch and mar resistance
• Provided material compliant with FDA 21
CFR 177.1210
• Supplied both the base resin and at-press
colorant to meet OEM specifications
• Offered TPV alloy grade that enabled easy
processing and durable surface aesthetics
• Specified material in North America with
design engineers and supplied out of a
facility in China to meet production needs
Versalloy™ XL Thermoplastic Elastomer
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Summary%2520and%2520QA.pdf
Newlin
Page 105
Old
PolyOne
Transformation
60%
80%
100%
%
o
f
O
p
ra
ti
g
I
co
m
*
Mix Shift Highlights Specialty Transformation
Ahead of Schedule
2015
Target
*Operating Income excludes Corporate Charges
** Pro Forma for the acquisition of ColorMatrix and divestiture of SunBelt
2%
34%
42%
50%
65-75%
0%
20%
40%
2005 2008 2011 2011** 2015
%
o
f
O
p
ra
ti
g
I
co
m
*
JV's PP&S Distribution Specialty
Specialty OI $5M $46M $89M $117M Target
Page 106
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2024-07/CCG Application Snapshot Evoluscend Mold Release_Final.pdf
PowerPoint Presentation
M E D I C A L C O N N E C T O R S
• Ongoing production with no change to regular set up
• Excellent processing and demolding performance
• Color stability during processing
• Excellent chemical and impact resistance
• Enabled efficient ongoing production rates without
changing any processing parameters
• Safeguarded color stability and transparency
during processing for optimal aesthetics
• Ensured regulatory requirements for
biocompatible ISO109931 and FDA were met
• Provided a solution effective across a range of
high-temperature polymers, including PEEK,
PPSU, PES, PSU, PEI, LCP, and PPS
Colorant Chromatics Evoluscend non-
PFAS* high-temperature polymer mold release
additive
KEY REQUIREMENTS WHY AVIENT
AVIENT SOLUTION
PRODUCTIVITY + REGULATORY
LEARN MORE
ELECTRICAL
COMPONENT OEM
(*) A non-PFAS additive manufactured without non-intentionally added (NIA) PFAS or PTFE.
(*) manufactured without intentionally added PFAS and without PTFE
(1) refers to sulfone products only
https://www.avient.com/products/polymer-additives/processing-enhancement-additives/colorant-chromatics-evoluscend-non-pfas-high-temperature-mold-release-additive
Slide Number 1